White label ELPA - ClinicalTrials.eu

Long-Term Safety and Efficacy of Lebrikizumab in Children and Adolescents With Moderate-to-Severe Atopic Dermatitis

Recruiting

3 1
Investigated diseases:
- Dermatitis atopic
- Eczema
Investigated drugs:
- Lebrikizumab
Corabotase for Moderate to Severe Glabellar Lines in Adults

Recruiting

3 1
Investigated diseases:
- Skin wrinkling
Investigated drugs:
- Clostridium Botulinum, Neurotoxin Serotype A/B
RO7795068 for Weight Loss in Adults With Obesity or Overweight Without Type 2 Diabetes

Recruiting

3 1

+3
N1T-MC-MALO: A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Who Are at Increased Risk of Developing Major Adverse Liver Outcomes (SYNERGY-Outcomes); N1T-MC-TZ01 Tirzepatide in participants with high-risk MASLD; N1T-MC-RT01 Retatrutide in participants with high-risk MASLD

Recruiting

3 1
Investigated diseases:
- Metabolic dysfunction-associated liver disease
Investigated drugs:
- Ly3437943 Sodium
- Tirzepatide
+9
Phase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC

Recruiting

3 1 1 1
Investigated diseases:
- Non-small cell lung cancer
- Non-small cell lung cancer metastatic
Investigated drugs:
+3
A study to evaluate the safety and effectiveness of rilvegostomig, ramucirumab, and a drug combination in adults with advanced or metastatic non-small cell lung cancer

Recruiting

2 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
A study to evaluate the effect of nolasiban on uterine contractions in women undergoing IVF or ICSI treatments

Recruiting

2 1
Study of KAI-9531 in Adults With Obesity or Overweight and Weight-Related Health Problems Without Diabetes

Recruiting

3 1
Investigated diseases:
- Obesity
Investigated drugs:
- HRS 9531
Volrustomig in Patients with Unresectable Pleural Mesothelioma and Esophageal Squamous Cell Carcinoma

Recruiting

2 1 1 1
Investigated diseases:
- Neoplasm
Investigated drugs:
Long-Term Study of Imeroprubart in Adults With Graves’ Disease

Recruiting

2 1 1
Investigated drugs:
- IMEROPRUBART
+5

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies